<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Valérie O. Baede</style></author><author><style face="normal" font="default" size="100%">Michael Z. David</style></author><author><style face="normal" font="default" size="100%">Arjana Tambić Andrašević</style></author><author><style face="normal" font="default" size="100%">Dominique S. Blanc</style></author><author><style face="normal" font="default" size="100%">Michael Borg</style></author><author><style face="normal" font="default" size="100%">Grainne Brennan</style></author><author><style face="normal" font="default" size="100%">Boudewijn Catry</style></author><author><style face="normal" font="default" size="100%">Aurélie Chabaud</style></author><author><style face="normal" font="default" size="100%">Joanna Empel</style></author><author><style face="normal" font="default" size="100%">Hege Enger</style></author><author><style face="normal" font="default" size="100%">Hallin, Marie</style></author><author><style face="normal" font="default" size="100%">Marina Ivanova</style></author><author><style face="normal" font="default" size="100%">Andreas Kronenberg</style></author><author><style face="normal" font="default" size="100%">Kuntaman, Kuntaman</style></author><author><style face="normal" font="default" size="100%">Anders Rhod Larsen</style></author><author><style face="normal" font="default" size="100%">Katrien Latour</style></author><author><style face="normal" font="default" size="100%">Jodi A. Lindsay</style></author><author><style face="normal" font="default" size="100%">Bruno Pichon</style></author><author><style face="normal" font="default" size="100%">Dewi Santosaningsih</style></author><author><style face="normal" font="default" size="100%">Leo M. Schouls</style></author><author><style face="normal" font="default" size="100%">François Vandenesch</style></author><author><style face="normal" font="default" size="100%">Guido Werner</style></author><author><style face="normal" font="default" size="100%">Dorota Żabicka</style></author><author><style face="normal" font="default" size="100%">Helena Žemličková</style></author><author><style face="normal" font="default" size="100%">Harald Seifert</style></author><author><style face="normal" font="default" size="100%">Margreet C. Vos</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">MRSA surveillance programmes worldwide: moving towards a harmonised international approach</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Antimicrobial Agents</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antimicrobial resistance</style></keyword><keyword><style  face="normal" font="default" size="100%">epidemiology</style></keyword><keyword><style  face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Jan-03-2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">59</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Multinational surveillance programmes for methicillin-resistant Staphylococcus aureus (MRSA) are dependent on national structures for data collection. This study aimed to capture the diversity of national MRSA surveillance programmes and to propose a framework for harmonisation of MRSA surveillance. The International Society of Antimicrobial Chemotherapy (ISAC) MRSA Working Group conducted a structured survey on MRSA surveillance programmes and organised a webinar to discuss the programmes' strengths and challenges as well as guidelines for harmonisation. Completed surveys represented 24 MRSA surveillance programmes in 16 countries. Several countries reported separate epidemiological and microbiological surveillance. Informing clinicians and national policy-makers were the most common purposes of surveillance. Surveillance of bloodstream infections (BSIs) was present in all programmes. Other invasive infections were often included. Three countries reported active surveillance of MRSA carriage. Methodology and reporting of antimicrobial susceptibility, virulence factors, molecular genotyping and epidemiological metadata varied greatly. Current MRSA surveillance programmes rely upon heterogeneous data collection systems, which hampers international epidemiological monitoring and research. To harmonise MRSA surveillance, we suggest improving the integration of microbiological and epidemiological data, implementation of central biobanks for MRSA isolate collection, and inclusion of a representative sample of skin and soft-tissue infection cases in addition to all BSI cases.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue></record></records></xml>